For the current study, Hunter and colleagues enrolled 504 patients with moderate knee OA (Kellgren-Lawrence grade 2/3), randomizing them 2:1:1 to the following treatment regimens: TLC599 (n=252) ...

In my practice, ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) has shown remarkable results in providing long-term pain relief for my knee OA patients.